Vericel (VCEL) Cash from Investing Activities (2010 - 2026)

Vericel's (VCEL) quarterly Cash from Investing Activities came in at -$4.2 million in Q1 2026, up 72.26% year-on-year from -$2.4 million in Q1 2025, and up 74.37% quarter-over-quarter from -$16.4 million in Q4 2025.

Vericel (VCEL) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Vericel has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$4.2 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$4.2 million, up 72.26% year-over-year; the trailing twelve-month figure through Mar 2026 was -$33.0 million (up 51.99% YoY), and the FY2025 annual result was -$43.9 million, up 44.41% from the prior year.
  • Cash from Investing Activities came in at -$4.2 million for Q1 2026 at Vericel, up from -$16.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $4.6 million in Q3 2023 to a low of -$25.5 million in Q1 2024.
  • The 5-year median for Cash from Investing Activities is -$9.0 million (2025), against an average of -$9.8 million.
  • Across the five-year window, Cash from Investing Activities tumbled 1252.73% in 2022 and soared 663.01% in 2023, its largest moves.
  • Vericel's Cash from Investing Activities stood at -$21.7 million in 2022, then jumped by 62.78% to -$8.1 million in 2023, then sank by 81.14% to -$14.7 million in 2024, then declined by 11.87% to -$16.4 million in 2025, then soared by 74.37% to -$4.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$4.2 million (Q1 2026), -$16.4 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn -4.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.20 Mn
Mar 31, 2026 -4.20 Mn
Dec 31, 2025 -16.39 Mn
Dec 31, 2025 -16.39 Mn
Sep 30, 2025 -3.38 Mn
Sep 30, 2025 -3.38 Mn
Jun 30, 2025 -9.03 Mn
Jun 30, 2025 -9.03 Mn
Mar 31, 2025 -15.14 Mn
Mar 31, 2025 -15.14 Mn
Dec 31, 2024 -14.65 Mn
Dec 31, 2024 -14.65 Mn
Sep 30, 2024 -21.21 Mn
Sep 30, 2024 -21.21 Mn
Jun 30, 2024 -17.72 Mn
Jun 30, 2024 -17.72 Mn
Mar 31, 2024 -25.45 Mn
Mar 31, 2024 -25.45 Mn
Dec 31, 2023 -8.09 Mn
Dec 31, 2023 -8.09 Mn